📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial. (2024)

First Author: Hendrick J

Attributed to: Myeloid cells in type 2 immunity: unravelling susceptibility and resistance to tissue nematode infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ofid/ofad630

PubMed Identifier: 38312212

Publication URI: http://europepmc.org/abstract/MED/38312212

Type: Journal Article/Review

Volume: 11

Parent Publication: Open forum infectious diseases

Issue: 2

ISSN: 2328-8957